London-traded China Medical System Holdings Limited was successfully listed on the main board of the Hong Kong Stock Exchange on September 28, 2010 (Stock Code: 0867) and canceled the admission of shares to trade on London’s Alternative Investment Market (AIM) on the same day. After the overallotment option exercised, the company totally issued 1,143,691,440 shares and approximately financed 1 billion HK dollars.
Zhong Lun Law Firm acted as PRC legal counsel for the company and provided full legal services. The professional team included Chen Limin, Jack Lai, Yang Hui, Chen Jingeng and Ben Wu. UBS AG was hired as the sole book-runner for the offering.
China Medical System Holdings Limited principally engages in providing marketing, promotion and other additional services for prescription drugs in China with domestic and foreign professional pharmaceutical companies.